Diverse IgG subclass responses to adeno‐associated virus infection and vector administration
Open Access
- 21 November 2008
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 81 (1), 65-74
- https://doi.org/10.1002/jmv.21360
Abstract
Humoral immune responses occur following exposure to Adeno‐associated virus (AAV) or AAV vectors. Many studies characterized antibody responses to AAV, but human IgG subclass responses to AAV have not been previously described. In this study, IgG subclass responses were examined in serum samples of normal human subjects exposed to wild‐type AAV, subjects injected intramuscularly with AAV vectors and subjects injected intravascularly with AAV vectors. A diversity of IgG subclass responses to AAV capsid were found in different subjects. IgG1 was found to be the dominant response. IgG2, IgG3, and IgG4 responses were also observed in most normal human subjects; IgG2 and IgG3 each represented the major fraction of total anti‐AAV capsid IgG in a subset of normal donors. Subjects exposed to AAV vectors showed IgG responses to AAV capsid of all four IgG subclasses. IgG responses to AAV capsid in clinical trial subjects were inversely proportional to the level of pre‐existing anti‐AAV antibody and independent of the vector dose. The high levels of anti‐AAV capsid IgG1 can mask differences in IgG2, IgG3, and IgG4 responses that were observed in this study. Analysis of IgG subclass distribution of anti‐AAV capsid antibodies indicates a complex, non‐uniform pattern of responses to this viral antigen. J. Med. Virol. 81:65–74, 2009.Keywords
This publication has 39 references indexed in Scilit:
- Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapyBlood, 2006
- Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primatesBlood, 2006
- Treatment of human disease by adeno-associated viral gene transferHuman Genetics, 2006
- Prolonged Activation of Virus-Specific CD8+T Cells after Acute B19 InfectionPLoS Medicine, 2005
- Genetic analysis of the antibody response to AAV2 and factor IXMolecular Therapy, 2005
- Anti-hepatitis B surface antigen IgG1 subclass is predominant in individuals who have recovered from hepatitis B virus infection, chronic carriers and vaccineesMedical Microbiology and Immunology, 2004
- IgG subclass response to human parvovirus B19 infectionClinical and Diagnostic Virology, 1996
- Primary biliary cirrhosis is associated with specific changes in liver IgG-bearing cell subpopulationsJournal of Hepatology, 1995
- Response to hepatitis B vaccine in a cohort of Gambian childrenThe Pediatric Infectious Disease Journal, 1995
- Subclass restriction of immunoglobulin G in liver cirrhosisJournal of Gastroenterology and Hepatology, 1990